Our research in heart disease prevention includes:
- Improved identification of heart disease markers. Mount Sinai Heart uses sophisticated imaging techniques to identify patients at high risk for cardiovascular disease. In collaboration with the Translational and Molecular Imaging Institute, Mount Sinai Heart is coordinating three national projects to identify visible markers of heart disease.
- Early-stage detection. Zahi Fayad, PhD, Professor of Cardiology and Director of the Translational and Molecular Imaging Institute, is using advanced magnetic resonance imaging (MRI) techniques to detect heart disease at the earliest stages.
- Targeting drug delivery. A potential application for MRI technology involves drug delivery. Oral medications are diluted in the bloodstream, so they are typically given at much higher doses than necessary. Detailed imaging allows doctors to better pinpoint the inflammation, and this could lead to more precise treatments.